Pfizer is leaving no stone unturned in its efforts to prevent Novo Nordisk from stealing off with Metsera, the weight-loss therapy developer it is hoping to acquire in a deal worth up to $7.3 billion.

Mar. 17, 2026 A new clinical study suggests that successful root canal treatment may benefit more than just dental health. Patients treated for infected teeth showed improved blood sugar control, ...